Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Licensed oral weight management options in the UK include orlistat
Eli Lilly developed it as a peptide that simultaneously activates three metabolic receptor systems
Contraindications/Precautions: Who should not take this medication? Patients with early hereditary optic nerve atrophy, cyanocobalmin hypersensitivity, and those who are pregnant
They are not identical copies of amylin, and they do not share the same receptor selectivity, molecular engineering, clinical database, or stage of development
Dosing is discussed at all because cagrilintide produced clinically meaningful weight reduction as a standalone agent in a phase 2 dose-finding trial, and because it is the amylin half of CagriSema the fixed-dose cagrilintide/semaglutide combination that Novo Nordisk filed with the FDA in December 2025
This means your healthcare provider must provide details to show why you need this medication
